Nouveau Life Pharmaceuticals, Inc.

OTCPK:NOUV Stock Report

Market Cap: US$999.1k

Nouveau Life Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Brian Shibley

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6yrs
CEO ownershipn/a
Management average tenure18.5yrs
Board average tenure18.8yrs

Recent management updates

No updates

Recent updates

No updates

CEO

Brian Shibley

6yrs

Tenure

Mr. Brian Shibley serves as Director of North American Cannabis Holdings, Inc. Mr. Shibley serves as the Chief Executive Officer and Chairman at Puration, Inc. Mr. Shibley served as an Interim Chief Execut...

Leadership Team

NamePositionTenureCompensationOwnership
Douglas Dickie
Chief Financial Officer and Director18.5yrsno datano data
Brian Shibley
Chairman of the Board6yrsno datano data
Darcy Penner
Manager of Investor Relationsno datano datano data
Rolly Hein
Acting Vice President and Director18.8yrsno datano data
Warren Wheeler
Treasurerno datano datano data

18.5yrs

Average Tenure

Experienced Management: NOUV's management team is seasoned and experienced (18.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Douglas Dickie
Chief Financial Officer and Director18.8yrsno datano data
Brian Shibley
Chairman of the Boardno datano datano data
Rolly Hein
Acting Vice President and Director18.8yrsno datano data
Warren Wheeler
Treasurerno datano datano data
Alan Urschel
Member of Technical Advisory Committeeno dataUS$13.67kno data
Edward Melenka
Independent Director18.5yrsno datano data

18.8yrs

Average Tenure

78.5yo

Average Age

Experienced Board: NOUV's board of directors are seasoned and experienced ( 18.8 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/12 13:37
End of Day Share Price 2025/01/10 00:00
Earnings2008/03/31
Annual Earnings2007/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nouveau Life Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution